← Issue №15/ week of Oct 11, 2026/IBD

Evolving Treatment Patterns and Clinical Outcomes in Children with Newly Diagnosed Crohn's Disease and Ulcerative Colitis in the United States, 2007-2023.

From GI Signals issue №15: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD prospective cohort · n=1,186 · Oct 6, 2026 · Am J Gastro · IF 9.8

Evolving Treatment Patterns and Clinical Outcomes in Children with Newly Diagnosed Crohn's Disease and Ulcerative Colitis in the United States, 2007-2023.

New evidencepediatricCrohn's diseaseulcerative colitisbiologics
Clinical takeawayChildren diagnosed with Crohn's in 2019-23 were less often hospitalized (HR 0.65, 95% CI 0.43-0.97 vs 2007-12) as advanced therapy rose and steroid use fell; this is an era comparison, not a causal test of early advanced therapy, though it is consistent with guideline support for early anti-TNF in high-risk pediatric Crohn's.
What it foundIn children with newly diagnosed Crohn's disease, 5-year risk of IBD-related hospitalization and major surgery was 30% and 10%, respectively; in ulcerative colitis, 5-year risk was 36% and 8%.
ContextConfirms the trend toward early advanced therapy in pediatric IBD, though surgical risk did not significantly decline despite increased use, and findings are hypothesis-generating rather than conclusive.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Gonzalez MM … Singh S · American Journal of Gastroenterology · IF 9.8 · PubMed ↗Permalink
← Read the whole of issue №15 Every paper GI Signals surfaces gets a page like this one. All issues